These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 20717826)
1. Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma. Le Dortz L; De Guibert S; Bayat S; Devillers A; Houot R; Rolland Y; Cuggia M; Le Jeune F; Bahri H; Barge ML; Lamy T; Garin E Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2307-14. PubMed ID: 20717826 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement. Iwamuro M; Okada H; Takata K; Shinagawa K; Fujiki S; Shiode J; Imagawa A; Araki M; Morito T; Nishimura M; Mizuno M; Inaba T; Suzuki S; Kawai Y; Yoshino T; Kawahara Y; Takaki A; Yamamoto K World J Gastroenterol; 2012 Nov; 18(44):6427-36; discussion p.6434. PubMed ID: 23197888 [TBL] [Abstract][Full Text] [Related]
3. Systematic Review on the Additional Value of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Staging Follicular Lymphoma. Adams HJ; Nievelstein RA; Kwee TC J Comput Assist Tomogr; 2017 Jan; 41(1):98-103. PubMed ID: 27560022 [TBL] [Abstract][Full Text] [Related]
4. The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi. Luminari S; Biasoli I; Arcaini L; Versari A; Rusconi C; Merli F; Spina M; Ferreri AJ; Zinzani PL; Gallamini A; Mastronardi S; Boccomini C; Gaidano G; D'Arco AM; Di Raimondo F; Carella AM; Santoro A; Musto P; Federico M Ann Oncol; 2013 Aug; 24(8):2108-12. PubMed ID: 23585513 [TBL] [Abstract][Full Text] [Related]
5. [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study. Martelli M; Ceriani L; Zucca E; Zinzani PL; Ferreri AJ; Vitolo U; Stelitano C; Brusamolino E; Cabras MG; Rigacci L; Balzarotti M; Salvi F; Montoto S; Lopez-Guillermo A; Finolezzi E; Pileri SA; Davies A; Cavalli F; Giovanella L; Johnson PW J Clin Oncol; 2014 Jun; 32(17):1769-75. PubMed ID: 24799481 [TBL] [Abstract][Full Text] [Related]
6. [Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients]. Oriuchi N; Higuchi T; Endo K; Tsukamoto N; Matsuda H; Kuji I; Murakami K; Nakajima K Kaku Igaku; 2009 Jun; 46(2):96-9. PubMed ID: 19637820 [TBL] [Abstract][Full Text] [Related]
7. Positron-emission tomography-based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma. Batlevi CL; Sha F; Alperovich A; Ni A; Smith K; Ying Z; Gerecitano JF; Hamlin PA; Horwitz SM; Joffe E; Kumar A; Matasar MJ; Moskowitz AJ; Moskowitz CH; Noy A; Owens C; Palomba LM; Straus D; von Keudell G; Zelenetz AD; Seshan VE; Luminari S; Marcheselli L; Federico M; Younes A Eur J Cancer; 2020 Feb; 126():78-90. PubMed ID: 31927165 [TBL] [Abstract][Full Text] [Related]
8. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related]
9. Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS. Dupuis J; Berriolo-Riedinger A; Julian A; Brice P; Tychyj-Pinel C; Tilly H; Mounier N; Gallamini A; Feugier P; Soubeyran P; Colombat P; Laurent G; Berenger N; Casasnovas RO; Vera P; Paone G; Xerri L; Salles G; Haioun C; Meignan M J Clin Oncol; 2012 Dec; 30(35):4317-22. PubMed ID: 23109699 [TBL] [Abstract][Full Text] [Related]
10. Value of [18F]fluorodeoxyglucose positron emission tomography in the management of follicular lymphoma: the end of a dilemma? Janikova A; Bolcak K; Pavlik T; Mayer J; Kral Z Clin Lymphoma Myeloma; 2008 Oct; 8(5):287-93. PubMed ID: 18854283 [TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants. Trotman J; Fournier M; Lamy T; Seymour JF; Sonet A; Janikova A; Shpilberg O; Gyan E; Tilly H; Estell J; Forsyth C; Decaudin D; Fabiani B; Gabarre J; Salles B; Van Den Neste E; Canioni D; Garin E; Fulham M; Vander Borght T; Salles G J Clin Oncol; 2011 Aug; 29(23):3194-200. PubMed ID: 21747087 [TBL] [Abstract][Full Text] [Related]
12. 18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence. Isohashi K; Tatsumi M; Higuchi I; Inoue A; Nakajo K; Ishikawa J; Shimosegawa E; Kanakura Y; Nakamura H; Hatazawa J Ann Nucl Med; 2008 Nov; 22(9):795-802. PubMed ID: 19039558 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Importance of Bone Marrow Uptake on Baseline Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of interim ¹⁸F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma. Yang DH; Min JJ; Song HC; Jeong YY; Chung WK; Bae SY; Ahn JS; Kim YK; Bom HS; Chung IJ; Kim HJ; Lee JJ Eur J Cancer; 2011 Jun; 47(9):1312-8. PubMed ID: 21334197 [TBL] [Abstract][Full Text] [Related]
16. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET. Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial. Trotman J; Barrington SF; Belada D; Meignan M; MacEwan R; Owen C; Ptáčník V; Rosta A; Fingerle-Rowson GR; Zhu J; Nielsen T; Sahin D; Hiddemann W; Marcus RE; Davies A; Lancet Oncol; 2018 Nov; 19(11):1530-1542. PubMed ID: 30309758 [TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas. Kumar R; Xiu Y; Potenta S; Mavi A; Zhuang H; Yu JQ; Dhurairaj T; Dadparvar S; Alavi A J Nucl Med; 2004 Nov; 45(11):1796-803. PubMed ID: 15534046 [TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET and PET/CT in Burkitt's lymphoma. Karantanis D; Durski JM; Lowe VJ; Nathan MA; Mullan BP; Georgiou E; Johnston PB; Wiseman GA Eur J Radiol; 2010 Jul; 75(1):e68-73. PubMed ID: 19716248 [TBL] [Abstract][Full Text] [Related]
20. Imaging in follicular NHL. Hofman MS; Hicks RJ Best Pract Res Clin Haematol; 2011 Jun; 24(2):165-77. PubMed ID: 21658616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]